Effect of Music Therapy on Infants with Neonatal Abstinence Syndrome
- Conditions
- NAS
- Registration Number
- NCT03533985
- Lead Sponsor
- Icahn School of Medicine at Mount Sinai
- Brief Summary
This study examines the effects of 6 different music therapy interventions on outcomes for neonates diagnosed with Neonatal Abstinence Syndrome.
- Detailed Description
The purpose of this exploratory pilot study is to learn what, if any, effects live music therapy interventions have on the pacification, stabilization, and development of infants diagnosed with Neonatal Abstinence Syndrome (NAS). Neonatal Abstinence Syndrome is a group of problems that occur in a newborn who has been exposed to illegal or prescription opiates while in the mother's womb. Participants will receive 6 music therapy sessions over a 14-day period based on a randomized treatment schedule of 6 different interventions.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 200
Infants who meet the following inclusion criteria will be eligible to participate in the study irrespective of race, religion, ethnicity, or gender:
- Admitted to the NICU immediately postpartum
- Gestational age 28 weeks or older
- No identified hearing disorder
- Do not have a diagnosed developmental disability (i.e. Down Syndrome)
- Do not have Fetal Alcohol Syndrome
- Medically cleared to participate in the study by nurse or neonatologist
- Parent or legal guardian able/willing to give consent & complete the PBQ (Postpartum Bonding Questionnaire)
- Admitted to the NICU at any time other than immediately postpartum
- Gestational age <28 weeks old
- Has an identified hearing disorder
- Has diagnosed developmental disability (i.e. Down syndrome)
- Has Fetal Alcohol Syndrome
- Is not medically cleared to participate in the study by the nurse or neonatologist
- Parent or legal guardian unable/unwilling to give consent
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Primary Outcome Measures
Name Time Method O2 sats up to 2 weeks Oxygen saturation levels (O2 sats)
Heart Rate up to 2 weeks Feeding (sucking and absorption) category up to 2 weeks The neonatologist or nurse will rate feeding (sucking/absorption) from 1 (active/perpetual) to 12 (none/gavage)
Neonatal Abstinence Scoring (NAS) up to 2 weeks The NAS score lists 21 symptoms that are most frequently observed in opiate-exposed infants. Each symptom and its associated degree of severity are assigned a score and the total abstinence score is determined by totalling the score assigned to each symptom over the scoring period. Please provide the full scale info (example 0 (no symptoms) to 10 (severe symptoms)
Sleep category up to 2 weeks The neonatologist or nurse will assess and mark as quiet sleep, active sleep, drowsy state, alert inactivity, fussing or crying.
Activity level up to 2 weeks The neonatologist or nurse will assess and mark as active/alert, active to stimulation, flaccid, hypertonic, hypotonic, irritable, jittery, lethargic, paralyzed\&medicated, quiet, sedated, or tremors
Respiratory Rate up to 2 weeks
- Secondary Outcome Measures
Name Time Method Postpartum Bonding Questionnaire (PBQ ) Baseline Questionnaire to assess capacity for attachment in both mothers and fathers. 25 item scale with each item rated from always to never. Scoring is based on four categories: impaired bonding scores 0-60, rejection and pathological anger scores 0-35, infant-focused anxiety scores 0-20, and incipient abuse scores 0-10. Total range from 0 (good bonding) to 125 (poor bonding).
Trial Locations
- Locations (6)
Tulane University Hospital
🇺🇸New Orleans, Louisiana, United States
Joseph M. Sanzari Children's Hospital
🇺🇸Hackensack, New Jersey, United States
Northwell Health
🇺🇸New Hyde Park, New York, United States
Mount Sinai West
🇺🇸NY, New York, United States
Maria Fareri Children's Hospital
🇺🇸Valhalla, New York, United States
Drexel University/Hahnemann Hospital-College of Nursing and Health Professions
🇺🇸Philadelphia, Pennsylvania, United States
Tulane University Hospital🇺🇸New Orleans, Louisiana, United StatesMeghan Howell, MD, FAAPContact504-988-4158mhowell2@tulane.eduRachel Lee, MDContactrlee13@tulane.eduStacy Drury, MD, PhDContact